{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T23:47:37Z","timestamp":1783122457436,"version":"3.54.6"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T00:00:00Z","timestamp":1551312000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005941","name":"Dietmar Hopp Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005941","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Merck Serono"},{"name":"German Federal Ministry of Education and Research"},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Baden-W\u00fcrttemberg Ministry of Science, Research and the Arts"},{"DOI":"10.13039\/501100001661","name":"Ruprecht-Karls-Universit\u00e4t Heidelberg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001661","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12974-019-1425-4","type":"journal-article","created":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T13:07:52Z","timestamp":1551359272000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Myelinoclastic diffuse sclerosis (Schilder\u2019s disease) is immunologically distinct from multiple sclerosis: results from retrospective analysis of 92 lumbar punctures"],"prefix":"10.1186","volume":"16","author":[{"given":"S.","family":"Jarius","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Wildemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,28]]},"reference":[{"key":"1425_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF02901445","volume":"10","author":"P Schilder","year":"1912","unstructured":"Schilder P. Zur Kenntnis der sogenannten diffusen Sklerose (\u00fcber encephalitis periaxialis diffusa). Zeitschrift f\u00fcr die gesamte Neurologie und Psychiatrie. 1912;10:1\u2013160.","journal-title":"Zeitschrift f\u00fcr die gesamte Neurologie und Psychiatrie"},{"key":"1425_CR2","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jns.2011.03.038","volume":"306","author":"S Jarius","year":"2011","unstructured":"Jarius S, Paul F, Franciotta D, Ruprecht K, Ringelstein M, Bergamaschi R, et al. Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures. J Neurol Sci. 2011;306:82\u201390.","journal-title":"J Neurol Sci"},{"key":"1425_CR3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1742-2094-9-14","volume":"9","author":"S Jarius","year":"2012","unstructured":"Jarius S, Ruprecht K, Wildemann B, Kuempfel T, Ringelstein M, Geis C, et al. Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients. J Neuroinflammation. 2012;9:14.","journal-title":"J Neuroinflammation"},{"key":"1425_CR4","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00415-016-8360-4","volume":"264","author":"S Jarius","year":"2017","unstructured":"Jarius S, Eichhorn P, Franciotta D, Petereit HF, Akman-Demir G, Wick M, et al. The MRZ reaction as a highly specific marker of multiple sclerosis: re-evaluation and structured review of the literature. J Neurol. 2017;264:453\u201366.","journal-title":"J Neurol"},{"key":"1425_CR5","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1136\/jnnp.2007.133330","volume":"79","author":"S Jarius","year":"2008","unstructured":"Jarius S, Franciotta D, Bergamaschi R, Rauer S, Wandinger KP, Petereit HF, et al. Polyspecific, antiviral immune response distinguishes multiple sclerosis and neuromyelitis optica. J Neurol Neurosurg Psychiatry. 2008;79:1134\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1425_CR6","first-page":"486","volume":"253","author":"S Jarius","year":"2006","unstructured":"Jarius S, Franciotta D, Marchioni E, Hohlfeld R, Wildemann B, Voltz R. Intrathecal polyspecific immune response against neurotropic viruses discriminates between multiple sclerosis and acute demyelinating encephalomyelitis. J Neurol. 2006;253:486.","journal-title":"J Neurol"},{"key":"1425_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/2045-8118-9-14","volume":"9","author":"S Jarius","year":"2012","unstructured":"Jarius S, Eichhorn P, Wildemann B, Wick M. Usefulness of antibody index assessment in cerebrospinal fluid from patients negative for total-IgG oligoclonal bands. Fluids Barriers CNS. 2012;9:14.","journal-title":"Fluids Barriers CNS"},{"key":"1425_CR8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12974-017-0929-z","volume":"14","author":"S Jarius","year":"2017","unstructured":"Jarius S, Konig FB, Metz I, Ruprecht K, Paul F, Bruck W, et al. Pattern II and pattern III MS are entities distinct from pattern I MS: evidence from cerebrospinal fluid analysis. J Neuroinflammation. 2017;14:171.","journal-title":"J Neuroinflammation"},{"key":"1425_CR9","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jns.2008.08.002","volume":"280","author":"S Jarius","year":"2009","unstructured":"Jarius S, Eichhorn P, Jacobi C, Wildemann B, Wick M, Voltz R. The intrathecal, polyspecific antiviral immune response: specific for MS or a general marker of CNS autoimmunity? J Neurol Sci. 2009;280:98\u2013100.","journal-title":"J Neurol Sci"},{"key":"1425_CR10","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12974-016-0718-0","volume":"13","author":"S Jarius","year":"2016","unstructured":"Jarius S, Ruprecht K, Kleiter I, Borisow N, Asgari N, Pitarokoili K, Pache F, Stich O, Beume LA, Hummert MW, et al. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. J Neuroinflammation. 2016;13:280.","journal-title":"J Neuroinflammation"},{"key":"1425_CR11","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12974-016-0717-1","volume":"13","author":"S Jarius","year":"2016","unstructured":"Jarius S, Ruprecht K, Kleiter I, Borisow N, Asgari N, Pitarokoili K, Pache F, Stich O, Beume LA, Hummert MW, et al. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin. J Neuroinflammation. 2016;13:279.","journal-title":"J Neuroinflammation"},{"key":"1425_CR12","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jns.2007.11.004","volume":"268","author":"S Jarius","year":"2008","unstructured":"Jarius S, Hoffmann L, Clover L, Vincent A, Voltz R. CSF findings in patients with voltage gated potassium channel antibody associated limbic encephalitis. J Neurol Sci. 2008;268:74\u20137.","journal-title":"J Neurol Sci"},{"key":"1425_CR13","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1212\/WNL.56.10.1313","volume":"56","author":"S Schwarz","year":"2001","unstructured":"Schwarz S, Mohr A, Knauth M, Wildemann B, Storch-Hagenlocher B. Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients. Neurology. 2001;56:1313\u20138.","journal-title":"Neurology"},{"key":"1425_CR14","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1136\/jnnp.24.2.121","volume":"24","author":"K Schapira","year":"1961","unstructured":"Schapira K, Park DC. Gamma globulin studies of multiple sclerosis and their application to the problem of diagnosis. J Neurol Neurosurg Psychiatry. 1961;24:121\u20134.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1425_CR15","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1177\/1352458506070775","volume":"12","author":"H Butzkueven","year":"2006","unstructured":"Butzkueven H, Chapman J, Cristiano E, Grand\u2019Maison F, Hoffmann M, Izquierdo G, et al. MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosis. Mult Scler. 2006;12:769\u201374.","journal-title":"Mult Scler"},{"key":"1425_CR16","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1212\/01.WNL.0000144352.67102.BC","volume":"63","author":"D Pohl","year":"2004","unstructured":"Pohl D, Rostasy K, Reiber H, Hanefeld F. CSF characteristics in early-onset multiple sclerosis. Neurology. 2004;63:1966\u20137.","journal-title":"Neurology"},{"key":"1425_CR17","first-page":"99","volume":"4","author":"H Reiber","year":"1998","unstructured":"Reiber H. Cerebrospinal fluid--physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases. Mult Scler. 1998;4:99\u2013107.","journal-title":"Mult Scler"},{"key":"1425_CR18","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1177\/135245859800400304","volume":"4","author":"H Reiber","year":"1998","unstructured":"Reiber H, Ungefehr S, Jacobi C. The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis. Mult Scler. 1998;4:111\u20137.","journal-title":"Mult Scler"},{"key":"1425_CR19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12883-015-0330-4","volume":"15","author":"M Becker","year":"2015","unstructured":"Becker M, Latarche C, Roman E, Debouverie M, Malaplate-Armand C, Guillemin F. No prognostic value of routine cerebrospinal fluid biomarkers in a population-based cohort of 407 multiple sclerosis patients. BMC Neurol. 2015;15:79.","journal-title":"BMC Neurol"},{"key":"1425_CR20","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1001\/archneur.62.6.865","volume":"62","author":"MS Freedman","year":"2005","unstructured":"Freedman MS, Thompson EJ, Deisenhammer F, Giovannoni G, Grimsley G, Keir G, et al. Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement. Arch Neurol. 2005;62:865\u201370.","journal-title":"Arch Neurol"},{"key":"1425_CR21","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1017\/S0317167100045066","volume":"10","author":"KG Warren","year":"1983","unstructured":"Warren KG, Catz I, McPherson TA. CSF myelin basic protein levels in acute optic neuritis and multiple sclerosis. Can J Neurol Sci. 1983;10:235\u20138.","journal-title":"Can J Neurol Sci"},{"key":"1425_CR22","volume-title":"Laboratory diagnosis in neurology","author":"B Wildemann","year":"2011","unstructured":"Wildemann B, Oschmann P, Reiber H. Laboratory diagnosis in neurology. Stuttgart, New York: Thieme; 2011."},{"key":"1425_CR23","first-page":"69","volume":"11","author":"MR Ashrafi","year":"2017","unstructured":"Ashrafi MR, Tavasoli AR, Alizadeh H, Zare Noghabi J, Parvaneh N. Tumefactive multiple sclerosis variants: report of two cases of Schilder and Balo diseases. Iran J Child Neurol. 2017;11:69\u201377.","journal-title":"Iran J Child Neurol"},{"key":"1425_CR24","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1136\/jnnp.57.8.897","volume":"57","author":"M Andersson","year":"1994","unstructured":"Andersson M, Alvarez-Cermeno J, Bernardi G, Cogato I, Fredman P, Frederiksen J, et al. Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatry. 1994;57:897\u2013902.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1425_CR25","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17:162\u201373.","journal-title":"Lancet Neurol"},{"key":"1425_CR26","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/ana.20182","volume":"56","author":"CF Lucchinetti","year":"2004","unstructured":"Lucchinetti CF, Bruck W, Lassmann H. Evidence for pathogenic heterogeneity in multiple sclerosis. Ann Neurol. 2004;56:308.","journal-title":"Ann Neurol"},{"key":"1425_CR27","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","volume":"47","author":"C Lucchinetti","year":"2000","unstructured":"Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol. 2000;47:707\u201317.","journal-title":"Ann Neurol"},{"key":"1425_CR28","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1001\/archneur.64.6.903","volume":"64","author":"EM Frohman","year":"2007","unstructured":"Frohman EM, Kerr D. Is neuromyelitis optica distinct from multiple sclerosis? Something for \"lumpers\" and \u201csplitters\u201d. Arch Neurol. 2007;64:903\u20135.","journal-title":"Arch Neurol"},{"key":"1425_CR29","doi-asserted-by":"crossref","unstructured":"Jarius S, Paul F, Aktas O, Asgari N, Dale RC, de Seze J, et al. MOG encephalomyelitis: international recommendations on diagnosis and antibody testing. J Neuroinflammation. 2018;15:134.","DOI":"10.1186\/s12974-018-1144-2"},{"key":"1425_CR30","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/ana.24881","volume":"81","author":"EP Flanagan","year":"2017","unstructured":"Flanagan EP, Hinson SR, Lennon VA, Fang B, Aksamit AJ, Morris PP, et al. Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: analysis of 102 patients. Ann Neurol. 2017;81:298\u2013309.","journal-title":"Ann Neurol"},{"key":"1425_CR31","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12974-017-0900-z","volume":"14","author":"S Hahn","year":"2017","unstructured":"Hahn S, Trendelenburg G, Scharf M, Denno Y, Brakopp S, Teegen B, et al. Identification of the flotillin-1\/2 heterocomplex as a target of autoantibodies in bona fide multiple sclerosis. J Neuroinflammation. 2017;14:123.","journal-title":"J Neuroinflammation"},{"key":"1425_CR32","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/ana.24117","volume":"75","author":"MJ Titulaer","year":"2014","unstructured":"Titulaer MJ, Hoftberger R, Iizuka T, Leypoldt F, McCracken L, Cellucci T, et al. Overlapping demyelinating syndromes and anti-N-methyl-d-aspartate receptor encephalitis. Ann Neurol. 2014;75:411\u201328.","journal-title":"Ann Neurol"},{"key":"1425_CR33","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12974-017-1043-y","volume":"15","author":"S Jarius","year":"2018","unstructured":"Jarius S, Wurthwein C, Behrens JR, Wanner J, Haas J, Paul F, et al. Balo\u2019s concentric sclerosis is immunologically distinct from multiple sclerosis: results from retrospective analysis of almost 150 lumbar punctures. J Neuroinflammation. 2018;15:22.","journal-title":"J Neuroinflammation"},{"key":"1425_CR34","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1007\/s00415-013-6918-y","volume":"260","author":"M Wallner-Blazek","year":"2013","unstructured":"Wallner-Blazek M, Rovira A, Fillipp M, Rocca MA, Miller DH, Schmierer K, et al. Atypical idiopathic inflammatory demyelinating lesions: prognostic implications and relation to multiple sclerosis. J Neurol. 2013;260:2016\u201322.","journal-title":"J Neurol"},{"key":"1425_CR35","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s12974-016-0719-z","volume":"13","author":"S Jarius","year":"2016","unstructured":"Jarius S, Kleiter I, Ruprecht K, Asgari N, Pitarokoili K, Borisow N, Hummert MW, Trebst C, Pache F, Winkelmann A, et al. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: brainstem involvement - frequency, presentation and outcome. J Neuroinflammation. 2016;13:281.","journal-title":"J Neuroinflammation"},{"key":"1425_CR36","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12974-016-0720-6","volume":"13","author":"F Pache","year":"2016","unstructured":"Pache F, Zimmermann H, Mikolajczak J, Schumacher S, Lacheta A, Oertel FC, Bellmann-Strobl J, Jarius S, Wildemann B, Reindl M, et al. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients. J Neuroinflammation. 2016;13:282.","journal-title":"J Neuroinflammation"},{"key":"1425_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00415-013-7169-7","volume":"261","author":"C Trebst","year":"2013","unstructured":"Trebst C, Jarius S, Berthele A, Paul F, Schippling S, Wildemann B, et al. Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica study group (NEMOS). J Neurol. 2013;261:1\u201316.","journal-title":"J Neurol"},{"key":"1425_CR38","doi-asserted-by":"crossref","unstructured":"Jarius S, Wildemann B. The history of neuromyelitis optica. J Neuroinflammation. 2013;10:8","DOI":"10.1186\/1742-2094-10-8"},{"key":"1425_CR39","volume-title":"De la neuromy\u00e9lite optique aigu\u00eb. Th\u00e8se","author":"F Gault","year":"1894","unstructured":"Gault F. In: Rey A, editor. De la neuromy\u00e9lite optique aigu\u00eb. Th\u00e8se. Lyon: Facult\u00e9 de M\u00e9decine et de Pharmacie; 1894."},{"key":"1425_CR40","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1093\/qjmed\/os-23.91.343","volume":"23","author":"WR Brain","year":"1930","unstructured":"Brain WR. Critical review: disseminated sclerosis. QJM. 1930;23:343\u201391.","journal-title":"QJM"},{"key":"1425_CR41","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/cei.12271","volume":"176","author":"S Jarius","year":"2014","unstructured":"Jarius S, Wildemann B, Paul F. Neuromyelitis optica: clinical features, immunopathogenesis and treatment. Clin Exp Immunol. 2014;176:149\u201364.","journal-title":"Clin Exp Immunol"},{"key":"1425_CR42","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85:177\u201389.","journal-title":"Neurology"},{"key":"1425_CR43","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nrneurol.2010.72","volume":"6","author":"S Jarius","year":"2010","unstructured":"Jarius S, Wildemann B. AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance. Nat Rev Neurol. 2010;6:383\u201392.","journal-title":"Nat Rev Neurol"},{"key":"1425_CR44","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1001\/archneurpsyc.1928.02210080044002","volume":"19","author":"J Bal\u00f3","year":"1928","unstructured":"Bal\u00f3 J. Encephalitis periaxialis concentrica. Arch NeurPsych. 1928;19:242\u20136.","journal-title":"Arch NeurPsych"},{"key":"1425_CR45","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.clineuro.2004.02.005","volume":"106","author":"CM Poser","year":"2004","unstructured":"Poser CM, Brinar VV. The nature of multiple sclerosis. Clin Neurol Neurosurg. 2004;106:159\u201371.","journal-title":"Clin Neurol Neurosurg"},{"key":"1425_CR46","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/BF02895263","volume":"15","author":"P Schilder","year":"1913","unstructured":"Schilder P. Zur Frage der encephalitis periaxialis diffusa. Zeitschrift f\u00fcr die gesamte Neurologie und Psychiatrie. 1913;15:359\u201376.","journal-title":"Zeitschrift f\u00fcr die gesamte Neurologie und Psychiatrie"},{"key":"1425_CR47","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/BF01813381","volume":"71","author":"P Schilder","year":"1924","unstructured":"Schilder P. Die encephalitis periaxialis diffusa. Zeitschrift f\u00fcr die gesamte Neurologie und Psychiatrie. 1924;71:327\u201356.","journal-title":"Zeitschrift f\u00fcr die gesamte Neurologie und Psychiatrie"},{"key":"1425_CR48","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1600-0447.1956.tb09694.x","volume":"31","author":"CM Poser","year":"1956","unstructured":"Poser CM, Van Bogaert L. Natural history and evolution of the concept of Schilder\u2019 diffuse sclerosis. Acta Psychiatr Neurol Scand. 1956;31:285\u2013331.","journal-title":"Acta Psychiatr Neurol Scand"},{"key":"1425_CR49","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4322\/acr.2016.058","volume":"6","author":"M Kurdi","year":"2016","unstructured":"Kurdi M, Ramsay D. Balo\u2019s concentric lesions with concurrent features of Schilder\u2019s disease in relapsing multiple sclerosis: neuropathological findings. Autops Case Rep. 2016;6:21\u20136.","journal-title":"Autops Case Rep"},{"key":"1425_CR50","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1111\/bpa.12084","volume":"23","author":"S Jarius","year":"2013","unstructured":"Jarius S, Wildemann B. Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: a critical review of the literature. Brain Pathol. 2013;23:661\u201383.","journal-title":"Brain Pathol"},{"key":"1425_CR51","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1111\/j.1468-1331.2008.02315.x","volume":"15","author":"C Jacobi","year":"2008","unstructured":"Jacobi C, Hahnel S, Martinez-Torres F, Rieger S, Juttler E, Heiland S, et al. Prospective combined brain and spinal cord MRI in clinically isolated syndromes and possible early multiple sclerosis: impact on dissemination in space and time. Eur J Neurol. 2008;15:1359\u201364.","journal-title":"Eur J Neurol"},{"key":"1425_CR52","doi-asserted-by":"crossref","unstructured":"Vercellino M, Masera S, Lorenzatti M, Condello C, Merola A, Mattioda A, et al. Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter. J Neuropathol Exp Neurol. 2009;68:489\u2013502.","DOI":"10.1097\/NEN.0b013e3181a19a5a"},{"key":"1425_CR53","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1097\/01.jnen.0000190067.20935.42","volume":"64","author":"M Vercellino","year":"2005","unstructured":"Vercellino M, Plano F, Votta B, Mutani R, Giordana MT, Cavalla P. Grey matter pathology in multiple sclerosis. J Neuropathol Exp Neurol. 2005;64:1101\u20137.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1425_CR54","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1136\/jnnp.25.4.315","volume":"25","author":"B Brownell","year":"1962","unstructured":"Brownell B, Hughes JT. The distribution of plaques in the cerebrum in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1962;25:315\u201320.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1425_CR55","first-page":"217","volume-title":"Handbook of clinical neurology. Volume 9","author":"CE Lumsden","year":"1970","unstructured":"Lumsden CE. The neuropathology of multiple sclerosis. In: GWBE PJV, editor. Handbook of clinical neurology. Volume 9. Amsterdam: Elsevier; 1970. p. 217\u2013309."},{"key":"1425_CR56","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1212\/01.wnl.0000291010.54692.85","volume":"70","author":"S Mesaros","year":"2008","unstructured":"Mesaros S, Rocca MA, Absinta M, Ghezzi A, Milani N, Moiola L, et al. Evidence of thalamic gray matter loss in pediatric multiple sclerosis. Neurology. 2008;70:1107\u201312.","journal-title":"Neurology"},{"key":"1425_CR57","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1093\/brain\/awx247","volume":"140","author":"T Granberg","year":"2017","unstructured":"Granberg T, Fan Q, Treaba CA, Ouellette R, Herranz E, Mangeat G, et al. In vivo characterization of cortical and white matter neuroaxonal pathology in early multiple sclerosis. Brain. 2017;140:2912\u201326.","journal-title":"Brain"},{"key":"1425_CR58","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1056\/NEJMoa1100648","volume":"365","author":"CF Lucchinetti","year":"2011","unstructured":"Lucchinetti CF, Popescu BF, Bunyan RF, Moll NM, Roemer SF, Lassmann H, et al. Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med. 2011;365:2188\u201397.","journal-title":"N Engl J Med"},{"key":"1425_CR59","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/brain\/aww350","volume":"140","author":"M Jurynczyk","year":"2017","unstructured":"Jurynczyk M, Geraldes R, Probert F, Woodhall MR, Waters P, Tackley G, et al. Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis. Brain. 2017;140:617\u201327.","journal-title":"Brain"},{"key":"1425_CR60","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1136\/jnnp-2016-314005","volume":"88","author":"M Jurynczyk","year":"2017","unstructured":"Jurynczyk M, Tackley G, Kong Y, Geraldes R, Matthews L, Woodhall M, et al. Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease. J Neurol Neurosurg Psychiatry. 2017;88:132\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1425_CR61","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s00415-018-8781-3","volume":"265","author":"M Baumann","year":"2018","unstructured":"Baumann M, Grams A, Djurdjevic T, Wendel EM, Lechner C, Behring B, et al. MRI of the first event in pediatric acquired demyelinating syndromes with antibodies to myelin oligodendrocyte glycoprotein. J Neurol. 2018;265:845\u201355.","journal-title":"J Neurol"},{"key":"1425_CR62","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1056\/NEJM198410113111504","volume":"311","author":"R Eldridge","year":"1984","unstructured":"Eldridge R, Anayiotos CP, Schlesinger S, Cowen D, Bever C, Patronas N, et al. Hereditary adult-onset leukodystrophy simulating chronic progressive multiple sclerosis. N Engl J Med. 1984;311:948\u201353.","journal-title":"N Engl J Med"},{"key":"1425_CR63","doi-asserted-by":"publisher","DOI":"10.1007\/3-540-27660-2","volume-title":"Magnetic resonance of myelination and myelin disorders. 3rd edition edn","author":"MS Knaap van der","year":"2005","unstructured":"van der Knaap MS, Valk J. Magnetic resonance of myelination and myelin disorders. 3rd edition edn. Heidelberg, Berlin, New York: Springer; 2005."},{"key":"1425_CR64","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1177\/1352458515593406","volume":"22","author":"S Ramanathan","year":"2016","unstructured":"Ramanathan S, Prelog K, Barnes EH, Tantsis EM, Reddel SW, Henderson AP, et al. Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis. Mult Scler. 2016;22:470\u201382.","journal-title":"Mult Scler"},{"key":"1425_CR65","first-page":"107","volume":"77","author":"CM Poser","year":"1986","unstructured":"Poser CM, Goutieres F, Carpentier MA, Aicardi J. Schilder\u2019s myelinoclastic diffuse sclerosis. Pediatrics. 1986;77:107\u201312.","journal-title":"Pediatrics"},{"key":"1425_CR66","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1177\/088307380101600915","volume":"16","author":"AK Afifi","year":"2001","unstructured":"Afifi AK, Follett KA, Greenlee J, Scott WE, Moore SA. Optic neuritis: a novel presentation of Schilder\u2019s disease. J Child Neurol. 2001;16:693\u20136.","journal-title":"J Child Neurol"},{"key":"1425_CR67","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1136\/jnnp.66.3.407","volume":"66","author":"V Leuzzi","year":"1999","unstructured":"Leuzzi V, Lyon G, Cilio MR, Pedespan JM, Fontan D, Chateil JF, et al. Childhood demyelinating diseases with a prolonged remitting course and their relation to Schilder\u2019s disease: report of two cases. J Neurol Neurosurg Psychiatry. 1999;66:407\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1425_CR68","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1080\/026886902320909187","volume":"16","author":"K Kotil","year":"2002","unstructured":"Kotil K, Kalayci M, Koseoglu T, Tugrul A. Myelinoclastic diffuse sclerosis (Schilder\u2019s disease): report of a case and review of the literature. Br J Neurosurg. 2002;16:516\u20139.","journal-title":"Br J Neurosurg"},{"key":"1425_CR69","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1159\/000028695","volume":"29","author":"PC Garell","year":"1998","unstructured":"Garell PC, Menezes AH, Baumbach G, Moore SA, Nelson G, Mathews K, et al. Presentation, management and follow-up of Schilder\u2019s disease. Pediatr Neurosurg. 1998;29:86\u201391.","journal-title":"Pediatr Neurosurg"},{"key":"1425_CR70","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.3171\/jns.2002.97.6.1447","volume":"97","author":"F Nejat","year":"2002","unstructured":"Nejat F, Eftekhar B. Decompressive aspiration in myelinoclastic diffuse sclerosis or Schilder disease. Case report. J Neurosurg. 2002;97:1447\u20139.","journal-title":"J Neurosurg"},{"key":"1425_CR71","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1093\/brain\/awp070","volume":"132","author":"JM Frischer","year":"2009","unstructured":"Frischer JM, Bramow S, Dal-Bianco A, Lucchinetti CF, Rauschka H, Schmidbauer M, et al. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain. 2009;132:1175\u201389.","journal-title":"Brain"},{"key":"1425_CR72","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1136\/jnnp.53.10.918","volume":"53","author":"MD Johnson","year":"1990","unstructured":"Johnson MD, Lavin P, Whetsell WO Jr. Fulminant monophasic multiple sclerosis, Marburg\u2019s type. J Neurol Neurosurg Psychiatry. 1990;53:918\u201321.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1425_CR73","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/ana.21117","volume":"61","author":"A Ascherio","year":"2007","unstructured":"Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol. 2007;61:288\u201399.","journal-title":"Ann Neurol"},{"key":"1425_CR74","doi-asserted-by":"crossref","unstructured":"Ruprecht K, Wildemann B, Jarius S. Low intrathecal antibody production despite high seroprevalence of Epstein-Barr virus in multiple sclerosis: a review of the literature. J Neurol. 2018;265:239\u201352","DOI":"10.1007\/s00415-017-8656-z"},{"key":"1425_CR75","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1177\/1352458512463483","volume":"19","author":"A Harrer","year":"2013","unstructured":"Harrer A, Tumani H, Niendorf S, Lauda F, Geis C, Weishaupt A, et al. Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy. Mult Scler. 2013;19:1209\u201312.","journal-title":"Mult Scler"},{"key":"1425_CR76","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1177\/1352458511428465","volume":"18","author":"F Glehn von","year":"2012","unstructured":"von Glehn F, Farias AS, de Oliveira AC, Damasceno A, Longhini AL, Oliveira EC, et al. Disappearance of cerebrospinal fluid oligoclonal bands after natalizumab treatment of multiple sclerosis patients. Mult Scler. 2012;18:1038\u201341.","journal-title":"Mult Scler"},{"key":"1425_CR77","doi-asserted-by":"crossref","unstructured":"Bacigaluppi S, Polonara G, Zavanone ML, Campanella R, Branca V, Gaini SM, et al. Schilder's disease: non-invasive diagnosis? :A case report and review. Neurol Sci. 2009;30:421\u201330.","DOI":"10.1007\/s10072-009-0113-z"},{"key":"1425_CR78","unstructured":"Tselis AC, Lisak RP. Other demyelinating diseases. In: Freedman MS, editor. Multiple sclerosis and demyelinating diseases. Philadelphia: Lippincott Williams & Williams; 2006. p. 335\u201349."},{"key":"1425_CR79","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.msard.2018.09.001","volume":"26","author":"AM Dunn-Pirio","year":"2018","unstructured":"Dunn-Pirio AM, Eckstein C. Recurrent Schilder\u2019s disease. Mult Scler Relat Disord. 2018;26:8\u201310.","journal-title":"Mult Scler Relat Disord"},{"key":"1425_CR80","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1159\/000092785","volume":"55","author":"N Miyamoto","year":"2006","unstructured":"Miyamoto N, Kagohashi M, Nishioka K, Fujishima K, Kitada T, Tomita Y, et al. An autopsy case of Schilder\u2019s variant of multiple sclerosis (Schilder\u2019s disease). Eur Neurol. 2006;55:103\u20137.","journal-title":"Eur Neurol"},{"key":"1425_CR81","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s00415-003-1105-1","volume":"250","author":"J Sastre-Garriga","year":"2003","unstructured":"Sastre-Garriga J, Rovira A, Rio J, Tintore M, Grive E, Montalban X. Clinically definite multiple sclerosis after radiological Schilder-like onset. J Neurol. 2003;250:871\u20133.","journal-title":"J Neurol"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-019-1425-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12974-019-1425-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-019-1425-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T20:08:24Z","timestamp":1663013304000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-019-1425-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,28]]},"references-count":81,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1425"],"URL":"https:\/\/doi.org\/10.1186\/s12974-019-1425-4","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,28]]},"assertion":[{"value":"11 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"BW reports grants from German Ministry of Education and Research, grants from Dietmar Hopp Foundation, grants from Klaus Tschira Foundation, personal fees from Bayer Healthcare, personal fees from Biogen, grants and personal fees from Merck Serono, grants and personal fees from Novartis, grants and personal fees from Sanofi Genzyme, grants and personal fees from TEVA, outside the submitted work.FP has received research support from Bayer, Novartis, Biogen Idec, Teva, Sanofi-Aventis\/Genzyme, Merck Serono, Alexion, Chugai, Arthur Arnstein Foundation Berlin, Guthy Jackson Charitable Foundation and the US National Multiple Sclerosis Society; has received travel funding and\/or speaker honoraria from Bayer, Novartis, Biogen Idec, Teva, Sanofi-Aventis\/Genzyme and Merck Serono; and has consulted for Sanofi Genzyme, Biogen Idec and MedImmune; none of this is related to the present paper.The other authors report no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"51"}}